Importantly, therapeutic concentrations of LTG also significantly changed the channel function and the authors suggested that LTG may increase the risk of cardiac arrhythmia in individuals carrying mutations in cardiac arrhythmia genes. This evidence concerns the gene TNFSF14 and chronic obstructive pulmonary disease.